Overview

The emerging field of precision cancer medicine, in which the use of molecular data at the point of care directly impacts patient treatment and clinical decision-making, has already had a substantial, direct clinical impact on many aspects of medical oncology. The introduction of large-scale genomic technologies at the point of care has catalyzed discoveries in translational oncology and is driving new research that aims to dissect selective responses to targeted, immune-driven therapies and to chemotherapies, as well as identifying novel targets for which therapies are now in development. However, precision cancer medicine remains a promise rather than a solid and robust reality. Although the molecular landscapes of many cancers have been revealed using precision oncology approaches, many of the alterations observed in patients remain undruggable, and viable targets are incompletely characterized. In this conference we will discuss and address current advances, challenges and ignite solutions for the advancement of precision medicine.

Topics

  • Recent Advances in Cell Free DNA
  • Evolution of Liquid Biopsies in Clinical Practice
  • Breakthroughs in Immunotherapies
  • Emerging Biomarkers and Their Role in Disease
  • Big Data: Challenges and Opportunities
  • Multi-omic Approaches to Disease
  • Quality & Harmonization: QC, PT and Reference Materials

Emerging Knowledge Sessions

These general sessions will feature presentations from prominent experts on topics at the forefront of molecular diagnostics, such as:

  • Recent Advances in Cell Free DNA
  • Evolution of Liquid Biopsies in Clinical Practice
  • Breakthroughs in Immunotherapies
  • Emerging Biomarkers and Their Role in Disease

 

Monday, April 30

9:15 AM – 10:45 AM
Recent Advances in Liquid Biopsies: Challenges and Solutions

5:15 PM – 6:15 PM
CRISPR

Tuesday, May 1

8:00 AM – 9:30 AM
Biological Themes Across Tumor Types

Wednesday, May 2

8:00 AM – 9:30 AM
Immunotherapies

3:15 PM – 4:45 PM
Clinically Significant Big Data

Innovation Laboratory Sessions

These sessions are designed to be highly interactive, where attendees will share experiences, discuss, and propose solutions to specific challenges. Topics include:

  • Big Data: Challenges and Opportunities
  • Multi-omic Approaches to Disease
  • Quality & Harmonization: QC, PT and Reference Materials

 

Monday, April 30

11:00 AM – 12:00 PM
Quality Control

Tuesday, May 1

11:30 AM – 1:00 PM
Tumor Mutational Burden

Wednesday, May 2

11:30 AM – 1:00 PM
Battle of the Bioinformatics Pipeline

Organizing Committee

Andrea-Ferreira-Gonzalez—current

Andrea Ferreira-Gonzalez, PhD

Virginia Commonwealth University, Richmond, USA
Chair
Rami-Mahfouz

Rami Mahfouz, MD, MPH

American University of Beirut Medical Center, Beirut, Lebanon
Vice Chair
Winand-Dinjens

Winand Dinjens, PhD

Erasmus MC, Rotterdam, The Netherlands
Member
Ernst-Jan-Speel

Ernst-Jan Speel, PhD

Maastricht University Medical Center, Maastricht, The Netherlands
Member
Albrecht-Stenzinger

Albrecht Stenzinger, MD

University Hospital Heidelberg, Heidelberg, Germany
Member
Laura-Tafe

Laura Tafe, MD

Dartmouth Hitchcock Medical Center, Lebanon, USA
Member